These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22001627)

  • 1. 5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal.
    Ohmura Y; Jutkiewicz EM; Yoshioka M; Domino EF
    J Pharmacol Sci; 2011; 117(2):121-4. PubMed ID: 22001627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
    Ohmura Y; Jutkiewicz EM; Domino EF
    Pharmacol Biochem Behav; 2011 Jun; 98(4):552-8. PubMed ID: 21354201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice.
    Patel D; Vishwakarma PK; Patel R; Jain NS
    Behav Brain Res; 2021 Feb; 399():112997. PubMed ID: 33166570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Wing VC; Shoaib M
    Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent model of nicotine abstinence syndrome.
    Malin DH; Lake JR; Newlin-Maultsby P; Roberts LK; Lanier JG; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1992 Nov; 43(3):779-84. PubMed ID: 1448472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.
    Hildebrand BE; Nomikos GG; Bondjers C; Nisell M; Svensson TH
    Psychopharmacology (Berl); 1997 Feb; 129(4):348-56. PubMed ID: 9085404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Magallanes N; Blair MB; Alexander MR; McDavid L; Spurgeon JL; Ennifar S; Fattom A
    Nicotine Tob Res; 2010 Apr; 12(4):438-44. PubMed ID: 20203107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Hebert KM; Conrad DL; Wilson OB
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):180-4. PubMed ID: 7862893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
    Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
    Kotagale NR; Chopde CT; Umekar MJ; Taksande BG
    Eur J Pharmacol; 2015 May; 754():190-8. PubMed ID: 25744879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible.
    Malin DH; Lake JR; Payne MC; Short PE; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1996 Jan; 53(1):81-5. PubMed ID: 8848464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.
    Mannucci C; Navarra M; Calzavara E; Caputi AP; Calapai G
    Phytomedicine; 2012 Sep; 19(12):1117-24. PubMed ID: 22921986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
    Bocknik SE; Kulkarni AS
    Neuropharmacology; 1974 Apr; 13(4):279-81. PubMed ID: 4546783
    [No Abstract]   [Full Text] [Related]  

  • 16. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
    Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Wilson OB
    Psychopharmacology (Berl); 1993; 112(2-3):339-42. PubMed ID: 7871039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
    Varani AP; Moutinho LM; Calvo M; Balerio GN
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens.
    Rada P; Jensen K; Hoebel BG
    Psychopharmacology (Berl); 2001 Aug; 157(1):105-10. PubMed ID: 11512050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.